Search

everythinglearnresearchcommunity

for

Search:↓

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

Udenafil may help hair grow by activating certain stem cells.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

The new hair loss treatment combining nitric oxide and minoxidil in a special carrier is effective for hair regrowth.

Apoptosis, not oxidative stress, is linked to aging in mice with mtDNA mutations.

Tadalafil and Finasteride may help treat aggressive melanoma.

Finasteride and minoxidil work best together for hair loss.

Finasteride can treat prostatic haematuria, but its use is controversial.

Drugs like PDEI may help hair disorders like AGA.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

Sildenafil, often used for erectile dysfunction, may help hair growth.

Caffeine shows promise for treating some types of hair loss, but more research is needed.

Nitric oxide is important for skin functions and both helps protect against and contributes to skin inflammation and sensitization.

Hormones, especially testosterone and DHT, are key for penis development and function, and testosterone therapy may help with erectile dysfunction in those with low levels.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

Some common medications can harm male fertility, but many effects can be reversed.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Stromal Vascular Fraction might help with male sexual dysfunction, but more research is needed to confirm its safety and effectiveness.

Quick, selective detection of tadalafil and finasteride in human plasma developed.